BioRestorative Therapies, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001641172-25-023211
- Form type
- 10-Q
- CIK
- 0001505497
- Primary document
- https://www.sec.gov/Archives/edgar/data/1505497/000164117225023211/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioRestorative Therapies, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $328,300 | - | - |
| Cost Of Revenue | $11,638 | - | - |
| Gross Profit | $316,662 | - | - |
| Operating Income | $-8.1M | - | - |
| Net Income | $-8.0M | - | - |
| Eps Basic | -0.94 | - | - |
| Eps Diluted | -0.94 | - | - |
| Cash And Equivalents | $1.6M | - | - |
| Total Assets | $8.5M | - | - |
| Total Liabilities | $3.7M | - | - |
| Shareholders Equity | $4.8M | - | - |
| Operating Cash Flow | $-5.5M | - | - |
| Capital Expenditures | $36,400 | - | - |